Medrx Co. Ltd. reported consolidated earnings results for the nine months ended September 30, 2015. For the nine months, the company reported consolidated net sales of JPY 35 million, operating loss of JPY 658 million, ordinary loss of JPY 645 million, net loss of JPY 531 million or JPY 79.44 per diluted share, compared to net sales of JPY 25 million, operating loss of JPY 803 million, ordinary loss of JPY 810 million, net loss of JPY 813 million or JPY 121.65 per diluted share, a year ago.

The company provided consolidated earnings guidance for the full year ending December 31, 2015. For the full year, the company is forecasting its net sales of JPY 32 million, operating loss of JPY 1,026 million, ordinary loss of JPY 1,000 million, net loss of JPY 887 million or JPY 132.67 per share.